Medicine & Life Sciences
Atypical Hemolytic Uremic Syndrome
100%
Paroxysmal Hemoglobinuria
93%
Alternative Complement Pathway
90%
Hemolysis
69%
Anemia
56%
Complement C3-C5 Convertases
52%
Blood Platelets
52%
eculizumab
50%
Complement Inactivating Agents
48%
Thrombotic Microangiopathies
45%
Complement System Proteins
42%
Haemolytic Anaemia
38%
Penetrance
38%
Complement Activation
38%
Liver Function Tests
37%
Germ-Line Mutation
37%
United States Food and Drug Administration
33%
Blood Cells
27%
Erythrocytes
26%
Stem Cells
24%
Monoclonal Antibodies
24%
Clinical Trials
21%
Transplants
20%
Inflammation
19%
Pharmaceutical Preparations
13%
Genes
13%
Therapeutics
5%